OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Forecast, Price & News

$0.87

0.00 (0.00%)

(As of 05/26/2023 08:48 PM ET)

Compare

Today's Range: $0.81
▼
$0.87
50-Day Range: $0.84
▼
$1.50
52-Week Range: $0.79
▼
$2.20

Volume: 9,400 shs
Average Volume: 28,054 shs
Market Capitalization: $14.82 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Insider Trades Headlines SEC Filings Short Interest

About Pressure BioSciences (OTCMKTS:PBIO) Stock

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

PBIO Stock News Headlines

May 22, 2023 | finance.yahoo.com

Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing

May 17, 2023 | marketwatch.com

InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023

May 29, 2023 | Legacy Research (Affiliate) (Ad)

Millionaire Trader Drops Bombshell… “The Only Trade You Will Ever Need”

“FORGET 99% of the Stock Market... Trade ONE Stock... ONCE Per Month – Over and Over Again!”

May 16, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record

May 16, 2023 | finance.yahoo.com

Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record

May 11, 2023 | msn.com

Innovation That Can Be A Game-Changer For At Least 2 Industries?

May 10, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux

May 10, 2023 | finance.yahoo.com

Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux

May 29, 2023 | Legacy Research (Affiliate) (Ad)

Millionaire Trader Drops Bombshell… “The Only Trade You Will Ever Need”

“FORGET 99% of the Stock Market... Trade ONE Stock... ONCE Per Month – Over and Over Again!”

May 9, 2023 | finance.yahoo.com

Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray

May 9, 2023 | benzinga.com

Pressure BioScience's Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux

April 27, 2023 | marketwatch.com

InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO) Announces Rapid Progress on Limited Offering of Exclusive THC Licenses for UST(TM) Platform

April 27, 2023 | americanbankingnews.com

Pressure BioSciences, Inc. (OTCMKTS:PBIO) Sees Large Drop in Short Interest

April 26, 2023 | finance.yahoo.com

Pressure BioSciences Updates Rapid Progress on Limited Offering of Exclusive THC Licenses for Revolutionary UltraShear Nanoemulsion Processing Platform

April 25, 2023 | benzinga.com

Pressure BioSciences Wins $1.5 Million Contract From CBD Supply MD To Bring A Potent Nano-CBD Topical Spray To Store Shelves In April

April 23, 2023 | americanbankingnews.com

Pressure BioSciences (OTCMKTS:PBIO) Shares Cross Below 200 Day Moving Average of $1.41

April 21, 2023 | finance.yahoo.com

Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform

April 18, 2023 | finance.yahoo.com

Pressure BioSciences Announces Expansion into Strategic Manufacturing Facilities with Premier Process Technologies Company, Artisan Industries

April 15, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance

April 13, 2023 | finance.yahoo.com

Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance

April 13, 2023 | finance.yahoo.com

Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance

April 8, 2023 | marketwatch.com

InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO), NutraLife Biosciences Partner to Develop, Distribute Next-Generation Nutraceuticals

March 28, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences Reports Fresh Sales Momentum for PBI Agrochem

March 24, 2023 | americanbankingnews.com

SeqLL (NASDAQ:SQL) & Pressure BioSciences (OTCMKTS:PBIO) Head to Head Survey

March 22, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified CBD

March 22, 2023 | seekingalpha.com

Pressure BioSciences lands $1.5M order for its UltraShear Nanoemulsified CBD

March 22, 2023 | finance.yahoo.com

Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified CBD

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

PBIO Company Calendar

Last Earnings: 4/12/2023
Today: 5/28/2023
Next Earnings (Estimated): 8/16/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:PBIO
CUSIP: N/A
CIK: 830656
Web: www.pressurebiosciences.com
Phone: 508-230-1828
Fax: 508-230-1829
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.59)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,080,000.00
Net Margins: -939.40%
Pretax Margin: -939.45%
Return on Equity: N/A
Return on Assets: -751.44%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.05
Quick Ratio: 0.03

Sales & Book Value

Annual Sales: $1.73 million
Price / Sales: 8.56
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.91) per share
Price / Book: -0.46

Miscellaneous

Outstanding Shares: 17,030,000
Free Float: 15,240,000
Market Cap: $14.82 million
Optionable: Not Optionable
Beta: 0.71

Key Executives

Mr. Richard T. Schumacher (Age 73)
Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director
Comp: $355.18k

Dr. Alexander V. Lazarev Ph.D. (Age 58)
Chief Science Officer
Comp: $202.34k

Dr. Edmund Y. Ting Ph.D. (Age 68)
Sc.D. Ph.D., Sr. VP of Engineering
Comp: $256.92k

John B. Hollister
Director of Sales & Marketing

Key Competitors

View All Competitors

PBIO Stock - Frequently Asked Questions

How have PBIO shares performed in 2023?: Pressure BioSciences' stock was trading at $1.30 on January 1st, 2023. Since then, PBIO stock has decreased by 33.1% and is now trading at $0.87.
View the best growth stocks for 2023 here.
Are investors shorting Pressure BioSciences?: Pressure BioSciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,300 shares, an increase of 283.3% from the April 30th total of 600 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is currently 0.1 days.
View Pressure BioSciences' Short Interest.
When is Pressure BioSciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 16th 2023.
View our PBIO earnings forecast.
How were Pressure BioSciences' earnings last quarter?: Pressure BioSciences, Inc. (OTCMKTS:PBIO) posted its quarterly earnings data on Wednesday, April, 12th. The company reported ($0.37) EPS for the quarter. The company had revenue of $0.61 million for the quarter.

What other stocks do shareholders of Pressure BioSciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS).
What is Pressure BioSciences' stock symbol?: Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO."
How do I buy shares of Pressure BioSciences?: Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Pressure BioSciences' stock price today?: One share of PBIO stock can currently be purchased for approximately $0.87.
How much money does Pressure BioSciences make?: Pressure BioSciences (OTCMKTS:PBIO) has a market capitalization of $14.82 million and generates $1.73 million in revenue each year. The company earns $-16,080,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.
How can I contact Pressure BioSciences?: Pressure BioSciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The official website for the company is www.pressurebiosciences.com. The company can be reached via phone at 508-230-1828, via email at ir@pressurebiosciences.com, or via fax at 508-230-1829.

This page (OTCMKTS:PBIO) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial